Advertisement

Respiratory System (General Introduction)

  • L. Puglisi
  • F. Maggi
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 13)

Abstract

Prostaglandins occur naturally in lungs and in bronchial tissues. The presence of a lipid extract from normal lung, possessing smooth muscle stimulating activity, had been detected (1,2) some years before Bergström reported the structural formulas of the primary prostaglandins, isolated from sheep vesicular glands (3, 4) .

Keywords

Pulmonary Circulation Bronchial Smooth Muscle Tracheal Smooth Muscle Prostaglandin Biosynthesis Pulmonary Vascular Smooth Muscle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    ELIASSON, R., (1959). Studies on Prostaglandins. Occurrence, Formation and Biological Actions. Acta Physiol.Scand. 45, suppl. 158.Google Scholar
  2. 2.
    LINN, B.O., SHUNK, C.H., FOLKERS, K., GANLEY, O. and ROBINSON, H.J., (1961). SRS-S Concentrates from Normal Swine Lung without Anaphylaxis. Bioch. Pharmacol. 8, 339–340.Google Scholar
  3. 3.
    BERGSTRÖM, S., DRESSLER, F., RYHAGE, R., SAMÜELSSON, B. and SJÖVALL, J., (1962). The isolation of two further prostaglandins from sheep prostate glands. Ark. for Kemi 19, 563–567.Google Scholar
  4. 4.
    BERGSTRÖM, S., RYHAGE, R., SAMÜELSSON, B. and SJÖVALL, J., (1962). The structure of prostaglandins E1, F and F . Acta Chem. Scand. 16, 501–502Google Scholar
  5. 5.
    BERGSTRÖM, S., DRESSLER, F., KRABICH, L., RYHAGE, R. and SJÖVALL, J., (1962). The isolation and structure of a smooth muscle stimulating factor in normal sheep and pig lungs. Ark for Kemi 20, 63–66.Google Scholar
  6. 6.
    SAMÜELSSON, B., (1964). Identification of Prostaglandin F in bovine lung. Prostaglandin and related factors 26, Biochim.Biophys. Acta, 84, 707–713.PubMedGoogle Scholar
  7. 7.
    ÄNGGÅRD, E., (1965). The isolation and determination of prostaglandins in lung of sheep, guinea pig, monkey and man. Biochem.Pharmacol. 14, 1507–1516.PubMedGoogle Scholar
  8. 8.
    KARIM, S.M.M., SANDLER, M, and WILLIAMS, E.D., (1967). Distribution of prostaglandins in human tissues. Brit.J. Pharmacol, Chemoth. 31, 340–344,Google Scholar
  9. 9.
    KARIM, S.M.M., HILLIER, K. and DEVLIN, J., (1968). Distribution of prostaglandins E1, E2, F and F in some animal tissues. J. Pharm. Pharmacol. 20, 749–753.PubMedGoogle Scholar
  10. 10.
    ÄNGGÅRP, E. and BERGSTRÖM, S., (1973). Biological effects of an unsaturated trihydroxiacid (PGF) from natural swine lung. Acta Physiol. Scand, 58, 1–12.Google Scholar
  11. 11.
    ANDERSEN, N.H. and RAMWELL, P.W., (1974). Biological aspects of prostaglandins. Arch. Int. Med. 133, 30–50.Google Scholar
  12. 12.
    CHRIST, E.J. and VAN DORP, D.A., (1973). Comparative aspects of prostaglandin biosynthesis in animal tissues. Adv. Biosc. 9, 35–38.Google Scholar
  13. 13.
    FLOWER, R.J. and BLACKWELL, G.J., (1976). The importance of phospholipase-A2 in prostaglandin biosynthesis. Biochem. Pharmacol, 25, 285–291.PubMedGoogle Scholar
  14. 14.
    HAMBERG, M. and SAMUELSSON, B., (1973). Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc.Natl. Acad. Sci. U.S.A. 70, 899–903.PubMedGoogle Scholar
  15. 15.
    WIODAWER, P. and SAMUELSSON, B., (1973). On the organization and mechanism of prostaglandin synthetase. J.biol. Chem. 248, 5673–5678.Google Scholar
  16. 16.
    HAMBERG, M., SVENSSON, J., WAKABAYASHI, T. and SAMUELSSON, B., (1974). Insolation and structure of two prostaglandin endopero-xides that cause platelet aggregation. Proc. Natl. Acad. Sci. U.S.A. 71, 345–349.PubMedGoogle Scholar
  17. 17.
    NUGTEREN, D. H. and HAZELOF, E., (1973). Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim. Biophys. Acta 326, 448–461.PubMedGoogle Scholar
  18. 18.
    HAMBERG, M., SVENSSON, J. and SAMUELSSON, B., (1975). Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc.Natl. Acad. Sci. U.S.A. 72, 2994.PubMedGoogle Scholar
  19. 19.
    VAN DORP, D.A., (1966). The biosynthesis of prostaglandins. Mem. Soc. Endocrinol. 14, 39–47.Google Scholar
  20. 20.
    ÄNGGÅRD, E. and SAMUELSSON, B., (1965). Biosynthesis of prostaglandins from arachidonic acid in guinea pig lung. J. biol. Chem. 240, 3518–3521.PubMedGoogle Scholar
  21. 21.
    PIPER, P.J. and VANE, J.R., (1969). The release of prostaglandins during anaphylaxis in guinea pig isolated lungs. In: Prostaglandins, Peptides and Amines, eds. P. Mantegazza and E.W. Horton. Acad. Press, London, p.p. 15–19Google Scholar
  22. 22.
    PIPER, P.J. and VANE, J.R., (1969). Release of additional factors in anaphylaxis and its antagonism by antiinflammatory drugs. Nature (London) 223, 29–35.Google Scholar
  23. 23.
    PIPER, P.J. and WALKER, J.L., (1973). The release of spasmogenic substances from human chopped lung tissue and its inhibition. Brit. J. Pharmacol. 47, 291–304.Google Scholar
  24. 24.
    VOGT, W., MEYER, V., KUNZE, H., LUFFT, E. and BABILLI, S., (1969). Entstehung von SRS-C in der durchströmten Meerschweinchenlunge durch Phospholipase A. Archiv für Pharmac. und Exp. Pathol. 262, 124–134.Google Scholar
  25. 25.
    PALMER, M.A., PIPER, P.J. and VANE, J.R., (1970). Release of vasoactive substances from lungs by injection of particles. Br.J. Pharmacol. 40, 547P–548P.PubMedGoogle Scholar
  26. 26.
    LINDSEY, H.E. and WYLLIE, J.H., (1970). Release of prostaglandins from embolized lungs. Br. J. Surgery 57, 738–741.Google Scholar
  27. 27.
    PIPER, P.J. and VANE, J.R., (1971). The release of prostaglandins from lung and other tissues. Ann. N.Y. Acad. Sci 180, 363–385.PubMedGoogle Scholar
  28. 28.
    BERRY, E., EDMONDS, J.F. and WYLLIE, J.H., (1971). Release of prostaglandin E2 and unidentified factors from ventilated lungs. Br. J. Surgery 58, 189–192.Google Scholar
  29. 29.
    WEIR, E.K., MC MURTRY, I.F., TUCKER, A., REVEES, F.T. and GROVER, R.F., (1976). Inhibition of prostaglandin synthesis or blockade of prostaglandin action increases the pulmonary pressor response to hypoxia. In: Advances in prostaglandin and thromboxane research. Eds. B. Samuelsson and R. Paoletti. Raven Press Vol. 2 p.p. 914–915.Google Scholar
  30. 30.
    SAID, S.I., HOVA, N. and YOSHIDA, T., (1975). Hypoxic pulmonary vasoconstriction in cats, modification by indomethacin and aspirine. Fed. Proc. 34, 1229.Google Scholar
  31. 31.
    SAID, S.I., KITAMURA, S. and VREIM, C., (1972). Prostaglandins: release from the lung during mechanical ventilation at large tidal volumes. J. Clin. Invest. 51, 83a–84a.Google Scholar
  32. 32.
    BURKA, J.F. and EYRE, P., (1974). A study of prostaglandins and prostaglandin antagonist in relation to anaphylaxis in calves. Can. J. Physiol, and Pharmacol. 52, 942–951.Google Scholar
  33. 33.
    SAID, S.I., YOSHIDA, T., KITAMURA, S. and VREIM, C., (1974). Release of prostaglandins and other humoral mediators during hypoxic breathing. J. Clin. Invest. 53, 69a.Google Scholar
  34. 34.
    VANE, J.R., (1974). The use of isolated organ for detecting active substances in the circulating blood. Br. J. Pharmacol. Chemother. 23, 360–363.Google Scholar
  35. 35.
    SAID, S.I., KITAMURA, S., YOSHIDA, T., PRESKITT, J. and HOLDEN, L.D., (1974). Humoral control of airways. Ann. N.Y. Acad. Sci. 221, 103–114.PubMedGoogle Scholar
  36. 36.
    SVENSSON, J., HAMBER, M. and SAMUELSSON, B., (1975). Prostaglandin endoperoxides IX. Characterization of rabbit aorta contracting substance (RCS) from guinea pig lung and human platelets. Acta Physiol. Scand. 94, 222–228.PubMedGoogle Scholar
  37. 37.
    ALABASTER, V.A. and BAKHLE, Y.S., (1970). The release of biologically substances from isolated lungs by 5-hydroxytryptamine and tryp-tamine. Br. J. Pharmacol. 40, 582P–583P.PubMedGoogle Scholar
  38. 38.
    BAKHLE, Y.S. and SMITH, T.W., (1972). Release of spasmogenic substances induced by vasoactive amine from isolated lungs. Br. J. Pharmacol. 46, 543P–544P.PubMedGoogle Scholar
  39. 39.
    PIPER, P.J., VANE, J.R. and WYLLIE, J.H., (1970). Inactivation of prostaglandins by the lungs. Nature (London) 225, 600–604.Google Scholar
  40. 40.
    GILMORE, N.I., VANE, J.R. and WYLLIE, J.H., (1968). Prostaglandin release by the spleen. Nature (London) 218, 1135–1140.Google Scholar
  41. 41.
    RAMWELL, P.W. and SHAW, J.E., (1970). Biological significance of prostaglandins. In: Recent Progress in hormone research. Acad. Press. N.Y., London 26, 139–187.Google Scholar
  42. 42.
    HAMBERG, M. and SAMUELSSON, B., (1971). On the metabolism of prostaglandins E1 and E2 in man. J. biol. Chem. 246, 6713–6721.PubMedGoogle Scholar
  43. 43.
    HAMBERG, M. and SAMUELSSON, B., (1972). On the metabolism of prostaglandins E1 and E2 in the guinea pig. J. biol. Chem. 247, 3495–3502.PubMedGoogle Scholar
  44. 44.
    GRÙEN, K. and SAMUELSSON, B., (1971). Quantitative studies on the synthesis in vivo of prostaglandins in the rat. Eur. J. Biochem. 22, 391–395.PubMedGoogle Scholar
  45. 45.
    HAMBERG, M., (1972). Inhibition of prostaglandin synthesis in man. Biochem. Biophys. Res. Comm. 49, 720–726.PubMedGoogle Scholar
  46. 46.
    HAMBERG, M., (1973), Quantitative studies on prostaglandin synthesis in man. II, Determination of the major urinary metabolite of prostaglandins F and F , Anal, Biochem. 55, 368–378.Google Scholar
  47. 47.
    STRANDBERG, K. and HAMBERG, M., (1974), Increased excretion of 5a, 7a dihydroxy-11-keto-tetranor-prostanoic acid on anaphylaxis in the guinea pig. Prostaglandins 6, 159–170.PubMedGoogle Scholar
  48. 48.
    GRANSTRÖM, E., (1972). On the metabolism of prostaglandin F in female subjects. Eur. J. Biochem. 27, 462–469.PubMedGoogle Scholar
  49. 49.
    HAMBERG, M., SVENSSON, J., HEDQVIST, P., STRANDBERG, K. and SAMUELSSON, B., (1976). Involvement of endoperoxides and thromboxanes in anaphylactic reaction. In: Advances in prostaglandin and thromboxane research. Vol. I. p.p. 495–501. Eds. B. Samuelsson and F. Paoletti. Raven Press, N.Y.Google Scholar
  50. 50.
    HAMBERG, M., HEDQVIST, P., STRANDBERG, K., SVENSON, J. and SAMUELSSON, B., (1975). Prostaglandin endoperoxides IV. Effects on smooth muscle. Life Sci. 16, 451–462.PubMedGoogle Scholar
  51. 51.
    VON EULER, U.S., (1934). Zur Kenntnis der pharmakologischen Wirkungen von Nativsekreten und Extrakten accessorischer Geschlechtsdrüsen. Arch. exp. Path. Pharmak. 175, 78–84.Google Scholar
  52. 53.
    HORTON, E.W., (1972). Prostaglandins. In: Mon. Endocrinol. 7, 1–197.Google Scholar
  53. 52.
    VON EULER, U.S., (1935). A depressor substance in the vesicular gland. J. Physiol. 84, 21P.Google Scholar
  54. 54.
    KARIM, S.M.M. and SOMERS, K., (1972). Cardiovascular and renal action of prostaglandins. In: The prostaglandins: Progress in Research. Ed. S.M.M. Karim. MTP Med. Tech. Publ. Co. Oxford, p.p. 165–203.Google Scholar
  55. 55.
    NAKANO, J., (1973). General pharmacology of prostaglandin. In: The prostaglandins. Pharmacological and therapeutic advances. Ed. M.F. Cuthbert. W. Heinemann. Lond. p.p. 23–124.Google Scholar
  56. 56.
    FERREIRA, S.H. and VANE, J.R., (1967). Prostaglandins: their disappearance from and release into the circulation. Nature (London) 216, 868–873.Google Scholar
  57. 57.
    VANE, J.R., (1968). The release and assay of hormones. Sci. Basic Med. 336, 358.Google Scholar
  58. 58.
    VANE, J.R., (1969). The release and fate of vasoactive hormones in the circulation. Br. J. Pharmacol. 35, 209–242.PubMedGoogle Scholar
  59. 59.
    BAKHLE, Y.S. and VANE, J.R., (1974). Pharmacokinetic function of the pulmonary circulation. Physiol. Rev. 54, 1007–1045.PubMedGoogle Scholar
  60. 60.
    MC GIFF, J.C., TERRAGNO, N.A., STRAND, J.C., LEE, J.B. and LONIGRO, A.J., (1969). Selective passage of prostaglandins across the lung. Nature (London) 223, 742–745.Google Scholar
  61. 61.
    GRANSTRÖM, E., (1967). On the metabolism of prostaglandin E1 in man. Prog. Biochem. Pharmacol. 3, 89–93.Google Scholar
  62. 62.
    BIRON, P., (1968). Vasoactive hormone metabolism by the pulmonary circulation. Clin. Res. 16, 112.Google Scholar
  63. 63.
    ÄNGGÅRD, E. and SAMUELSSON, B., (1966). Purification and properties of a 15-hydroxy prostaglandin dehydrogenase from swine lung. Arkiv for Kemi 25, 293–300.Google Scholar
  64. 64.
    ÄNGGÅRD, E., LARSSON, C. and SAMUELSSON, B., (1971). The distribution of 15-hydroxy prostaglandin dehydrogenase and prostaglandin- Δ13 — reductase in tissues of the swine. Acta Physiol. Scand. 81, 396–404.PubMedGoogle Scholar
  65. 65.
    RYAN, J.W., SMITH, V. and NIEMEYER, S., (1972). Angiotensin I: metabolism by plasma membrane of lung. Science 176, 64–66.PubMedGoogle Scholar
  66. 66.
    LARSSON, C. and ÄNGGÅRD, E., (1970).Distribution of prostaglandin metabolizing enzymes in tissues of the swine. Acta Pharmacol. Toxicol. 28, suppl. 1, 61.Google Scholar
  67. 67.
    CHINARD, F.P., ENNS, T. and NOLAN, M.F., (1962). The permeability of characteristics of the alveolar capillary barrier. Trans. Ass. Am. Physiol. 75, 253–261.Google Scholar
  68. 68.
    RYAN, J. W., NIEMEYER, R.S. and GOODWIN, D.W.,(1972). Metabolic fate of bradykinin, angiotensin I, adenine nucleotides and prostaglandins E1 and F in the pulmonary circulation. Adv.Exp.Med. Biol. 21, 259–265.Google Scholar
  69. 69.
    DAWSON, C.A., COZZINI, B.O. and LONIGRO, A.J., (1975). Metabolism of (2–14c) prostaglandin E1 on passage through the pulmonary circulation. Canad. J. Physiol. Pharmacol. 53, 610–615.Google Scholar
  70. 70.
    VONKEMAN, H., NUGTEREN, D.H. and VAN DORP, D.A., (1969). The action of prostaglandin 15-hydroxy-dehydrogenase on various prostaglandins. Biochim Biophys. Acta, 187, 581–583.PubMedGoogle Scholar
  71. 71.
    NAKANO, J., ÄNGGÅRD, E. and SAMUELSSON, B., (1969). 15-hydroxy-prostanoate dehydrogenase. Prostaglandins as substrates and inhibitors. Eur. J. Biochem. 11, 386–389.PubMedGoogle Scholar
  72. 72.
    BITO, L.Z., (1972). Accumulation and apparent active transport of prostaglandins by some rabbit tissues in vitro. J. Physiol. (London) 221, 371–387.Google Scholar
  73. 73.
    PIPER, P.J., (1973). Distribution and metabolism. In: The prostaglandins. Pharmacological and therapeutic advances. Ed. M.F. Cuthbert. W. Heinemann (London), p.p. 125–150.Google Scholar
  74. 74.
    ROSE, P; NEIDERHAUSER, U., PIPER, P.J., ROBINSON, E. and SMITH, A.P., (1976). Inactivation of prostaglandin F in the human pulmonary circulation. Br. J. Clin. Pharmacol. 3, 342.Google Scholar
  75. 75.
    PACE-ASCIAK, C.R., (1976). Biosynthesis and metabolism of prostaglandin during animal development. In: Advances in prostaglandin and thromboxane research. Vol. 1. Eds. B. Samuelsson and R. Paoletti, Raven Press N.Y., p.p. 35–46.Google Scholar
  76. 76.
    SUN, F.F. and ARMOUR, S.B., (1974). Prostaglandin 15-hydroxy-dehydrogenase and A13 reductase levels in the lungs of maternal, fetal and neonatal rabbits. Prostaglandins 7, 327–338.PubMedGoogle Scholar
  77. 77.
    ÄNGGÅRD, E. and SAMUELSSON, B., (1966). The metabolism of prostaglandins in lung tissue. In: Prostaglandins (Proc. Nobel Symp. 2). Eds. S. Bergström and B. Samuelsson. Inter-science Publ., N.Y. p.p. 97–105.Google Scholar
  78. 78.
    HORTON, E.W. and JONES, R.L., (1969). Prostaglandins A1, A2 and 19 hydroxy A1 , their actions on smooth muscle, and their inactivation on passage through the portal and pulmonary vascular bed. Br. J. Pharmacol. 37, 705–722.PubMedGoogle Scholar
  79. 79.
    DAWSON, W. and SWEATMAN, W.J.F., (1975). Possible role of prostaglandins in asthma. Int. Arch. Allergy Appl. Immun. 49, 213–216.Google Scholar
  80. 80.
    DAWSON, W., LEWIS, R.L., MC. MAHON, R.E. and SWEATMAN, W.J.F., (1974). Potent bronchoconstrictor activity of 15-keto prostaglandin F. Nature (London) 250, 331–332.Google Scholar
  81. 81.
    VANE, J.R., (1971). Inhibition of prostaglandin synthesis as a mechanism of aspirin like drugs. Nature, New Biol. 231, 232–235.Google Scholar
  82. 82.
    FLOWER, R.J. and VANE, J.R., (1974). Inhibition of prostaglandin biosynthesis. Biochem. Pharmacol. 23, 1439–1450.PubMedGoogle Scholar
  83. 83.
    DOWNINGS, D.T., AHERN, D.G. and BACHTA, M., (1970). Enzyme inhibition by acetylenic compounds. Biochem. Biophys. Res. Comm. 40, 218–223.Google Scholar
  84. 84.
    NIJKAMP, F.P., FLOWER, R.J., MONCADA, S. and VANE, J.R., (1976). Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by antiinflammatory steroids. Nature. 263, 479–482.PubMedGoogle Scholar
  85. 85.
    LEWIS, G.P. and PIPER, P.J., (1975). Inhibition of release of prostaglandins as an explanation of some of the action of antiinflammatory corticosteroids. Nature. 254, 308–311.PubMedGoogle Scholar
  86. 86.
    LEWIS, G.P. and PIPER, P.J., (1976). Inhibition of prostaglandin release by antiinflammatory steroids. In: Advances in prostaglandins and thromboxane research. Vol. 1. Eds. B. Samuelsson and R. Paoletti. Raven Press, p.p. 121–124.Google Scholar
  87. 87.
    GRYGLEWSKI, T.J., PANCZENKO, B., KORBUT, R., GRODZINSKA, L. and OCETKIEWCZ, A., (1975). Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lung of sensitized guinea pig. Prostaglandins 10, 343–355.PubMedGoogle Scholar
  88. 88.
    CRUTCHLEY, D.J. and PIPER, P.J., (1974). Prostaglandin inactivation in guinea pig lung and its inhibition. Br. J, Pharmacol. 52, 197–203.Google Scholar
  89. 89.
    EAKINS, K.E., KARIM, S.M.M. and MILLER, J.D., (1970). Antagonism of some smooth muscle action of prostaglandins by polyphloretin phosphate. Br. J. Pharmacol. 39, 556–563.PubMedGoogle Scholar
  90. 90.
    MATHE, A.A., STRANDBERG, K and ASTRÖM, A., (1971). Blockade by poliphloretin phosphate of the PGF action on isolated human bronchi. Nature New Biol. 230, 215–216.PubMedGoogle Scholar
  91. 91.
    MATHE, A.A., STRANDBERG, K and FREDHOLM, B., (1972). Antagonism of prostaglandin F induced broncho-constriction and blood pressure changes by polyphloretin phosphate in guinea pig and cat, J. Pharm. Pharmacol. 24, 378–382.PubMedGoogle Scholar
  92. 92.
    VILLANUEVA, R., HINDS, L., KATZ, R. and EAKINS, E.A., (1972) The effect of polyphloretin phosphate on some muscle action of prostaglandins in the cat. J. Pharmacol, Exp, Ther. 180, 78–85.Google Scholar
  93. 93.
    BITO, L.Z. and BAROODY, R.A., (1975). Inhibition of pulmonary prostaglandin metabolism by inhibitors of prostaglandin bio-transport (Probenecid and Bromcresol Green). Prostaglandins. 10, 633–639.PubMedGoogle Scholar
  94. 94.
    BITO, L.Z., (1975). Saturable, energy-dependent, transmembrane transport of prostaglandins against concentration gradient. Nature. 256, 134–136.PubMedGoogle Scholar
  95. 95.
    HORTON, E.W., (1969). Hypothesis on physiological roles of prostaglandins. Physiol. Rev. 49, 122–161.PubMedGoogle Scholar
  96. 96.
    LEWIS, A.J. and EYRE, P., (1972). Some cardiovascular and respiratory effects of prostaglandins E1, E2 and F in the calf. Prostaglandins 2, 55–64.PubMedGoogle Scholar
  97. 97.
    OKPAKO, D.T., (1972). The action of histamine and prostaglandins F and E2 on pulmonary vascular resistance of the lung of the guinea pig. J. Pharm. Pharmacol. 24, 40–46.PubMedGoogle Scholar
  98. 98.
    KADOWITZ, P.J., GEORGE, W.J., JOINER, P.D. and HYMAN, A.L., (1973). Effect of prostaglandins E1 and F on adrenergic responses in the pulmonary circulation. Adv. in Bioscience 9, Ed. S. Bergström. Pergamon Press, p.p. 501–506.Google Scholar
  99. 99.
    BURKA, J.E. and EYRE, P., (1974). Studies of prostaglandins and prostaglandin-antagonists on bovine pulmonary vein in vitro. Prostaglandins 6, 333–341.PubMedGoogle Scholar
  100. 100.
    STARLING, M.B. and ELLIOTT, R.B., (1974). The effects of prostaglandins, prostaglandin-inhibitors and oxygen on the closure of the ductus arteriosus, pulmonary arteries and umbilical vessels “in vitro”. Prostaglandins 8, 187–203.PubMedGoogle Scholar
  101. 101.
    KADOWITZ, P.J., JOINR, P.D. and HYMN, A.L., (1975). Physiological and pharmacological roles of prostaglandins. Ann. Rev. Pharmacol. 15, 285–306.PubMedGoogle Scholar
  102. 102.
    STRONG, C.G. and BOHR, D.F., (1967). Effects of prostaglandins E1 , E2, A1 and F on isolated vascular smooth muscle. Am. J. Physiol. 219, 725–733.Google Scholar
  103. 103.
    HAUGE, A., LUNDE, P.K.M. and WALER, B.A., (1967). Effects of prostaglandin E, and adrenaline on the pulmonary vascular resistance (PVR; in isolated rabbit lungs. Life Sci. 6, 637–680.Google Scholar
  104. 104.
    NAKANO, J. and MC CURDY, J.R., (1967) Effects of prostaglandins E1 (PGE1.) and A1. (PGA1.) on the systemic venous return and pulmonary circulation. Clin. Res. 15, 409.Google Scholar
  105. 105.
    MAXWELL, G.M., (1967). The effect of prostaglandin E upon the general and coronary hemodynamics and metabolism of the intact dog. Br. J. Pharmacol. 31, 162.Google Scholar
  106. 106.
    SAID, S.I., (1968). Some respiratory effects of prostaglandins E2 and F . In: Prostaglandin Symposium of the Worcester Foundation. Eds. P.W. Ramwell and J. E. Shaw. Intersciences N.Y.. p. 207.Google Scholar
  107. 107.
    DU CHARME, D.W., WEEKS, J.R. and MONTGOMERY, R.G., (1968). Studies of the hypertensive effect of prostaglandin F . J. Pharm. Exp. Ther. 160, 1.Google Scholar
  108. 108.
    GILES, T.D., QUIROZ, A.C. and BURCH, G.E., (1969). The effects of prostaglandin E1 on the systemic and pulmonary circulation of intact dogs. The influence of urethane and pentobarbital in anesthesia. Experientia 25, 1056.PubMedGoogle Scholar
  109. 109.
    NAKANO, J. and COLE, B., (1969). Effects of prostaglandins E1 and F on systemic, pulmonary and splanchnic circulation in dogs. 8m. J. Physiol. 217, 222.Google Scholar
  110. 110.
    KUIDA, H., (1971). Effects of prostaglandin. Bovine pulmonary circulation. Fed. Proc. 30, 380.Google Scholar
  111. 111.
    ALPERT, J.S., HAINES, F.W., KNUTSON, P.A., DALEN, J.E. and DEXTER, L., (1973). Prostaglandins and pulmonary circulation. Prostaglandins 3, 759–765.PubMedGoogle Scholar
  112. 112.
    KADOWITZ, P.J., JOINER, P.D. and HYMAN, A.L., (1975). Effect of prostaglandin E2 on pulmonary vascular resistance in intact dog, swine and lamb. Eur. J. Pharmacol. 31, 72–80.PubMedGoogle Scholar
  113. 113.
    HYMAN, A.L., (1969). The active responses of pulmonary veins in intact dogs to prostaglandins F and E1. J. Pharmacol. Exp. Ther. 165, 267–273.PubMedGoogle Scholar
  114. 114.
    HYMAN, A.L., WOOLVERTON, W.C., GUTH, P.S. and ICHINOSE, H., (1971) Pulmonary vasopressor response to decrease in blood pH in intact dogs. J. Clin. Invest. 50, 1028–1043.PubMedGoogle Scholar
  115. 115.
    BERGSTRÖM, S, CARLSON, L.A. and WEEKS, J., (1968). The prostaglandins: a family of biologically active lipids. Pharmacol. Rev. 20, 1–48.PubMedGoogle Scholar
  116. 116.
    NAKANO, J., (1973). General pharmacology of prostaglandins In: The prostaglandins pharmacological and therapeutics advances. Ed. M.F. Cuthbert, W. Heinemann, Ltd. London, p.p. 23–124Google Scholar
  117. 117.
    LESLIE, C.A. and LEVINE, L., (1973). Evidence for the presence of a prostaglandin E2 - 9 - ketoreductase in rat organs. Bio-chem. Biophys. Res. Comm. 52, 717.Google Scholar
  118. 118.
    SALZMAN, E.W., (1976). Prostaglandins and platelet function. In: “Advances in prostaglandin and thromboxane research. Vol. 2. Eds. B. Samuelsson and R. Paoletti. Raven Press. N.Y., p.p. 767–780.Google Scholar
  119. 119.
    MC QUEEN, D.S., (1972). The effects of some prostaglandins on respiration in rats and cats. Br. J. Pharmacol. 45, 147P 148P.Google Scholar
  120. 120.
    BROOKES, L.G. and MARSHALL, R.C., (1974). The effects of some prostaglandins on respiration in the rabbit. J. Pharm. Pharmacol. 26, suppl. 80P–81P.Google Scholar
  121. 121.
    SAID, S.I., MUREN, O. and KIRBY, B.J., (1968), Some respiratory effects of prostaglandins E2 and F . Clin. Res. 16, 90.Google Scholar
  122. 122.
    BERGSTRÖM, S., (1967). Prostaglandins, member of a new hormonal system. Science 157, 382–391.PubMedGoogle Scholar
  123. 123.
    CARLSON, L.A., EKELUND, L.G. and ORO, L., (1969). Circulatory and respiratory effects of different doses of PGE1 in man. Acta Physiol. Scand. 75, 161–169.PubMedGoogle Scholar
  124. 124.
    MC QUÙEN, D.S., (1974). The effects of some prostaglandins on respiration in anaesthetized cats. Br. J. Pharmacol. 50 559–568.Google Scholar
  125. 125.
    WASSERMAN, M.A., (1975). Bronchopulmonary responses to prostaglandin F , histamine and acetylcholine in the dog. Eur.J. Pharmacol. 32, 146–155.PubMedGoogle Scholar
  126. 126.
    WASSERMAN, M.A., (1975). Bronchopulmonary effects of prostaglandin F and three of its metabolites in the dog. Prostaglandins 9, 959–973.Google Scholar
  127. 127.
    WASSERMAN, M.A., (1976). Bronchopulmonary pharmacology of. some prostaglandin endoperoxide arialogs in the dog. Eur. J. Pharmacol. 36, 103–114.PubMedGoogle Scholar
  128. 128.
    PARKER, C.W. and SNIDER, D.E., (1973). Prostaglandins and asthma. Ann. Intern. Med. 78, 963.PubMedGoogle Scholar
  129. 129.
    CUTHBERT, M.F., (1975). Prostaglandins and asthma. Br. J. Clin. Pharmacol. 2, 293–295.PubMedGoogle Scholar
  130. 130.
    ROBISON, G.A. and SUTHERLAND, E.W., (1970). Sympathin E, sympathin I and the intracellular level of cyclic AMP. Circulation Res. Suppl. I, 26 and 27: 1–147 to 1–161.Google Scholar
  131. 131.
    BÄR, H.P., (1974). Cyclic nucleotides and smooth muscle. In: Advances in cyclic nucleotide research. Vol. 4. Eds. P. Greengard and G. A. Robison, Raven Press N.Y.. p.p. 195–237.Google Scholar
  132. 132.
    ANDERSSON, R., KÖVESI, G. and ERICSSON, E., (1975). Influence of contracting and relaxing drugs on cyclic AMP level in tracheal smooth muscle. Acta Physiol. Scand. (quoted by no. 135).Google Scholar
  133. 133.
    KALINER, M.A., ORANGE, R.P., KOOPMAN, W.J., AUSTEN, K.F. and LARAIA, P.J., (1971). Cyclic adenosin 3’, 5’, monophosphate in human lung. Biochim. Biophys. Acta, 252, 160–164.PubMedGoogle Scholar
  134. 134.
    KALINER, M.A., ORANGE, R.P. and AUSTEN, K.F., (1972). Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung: IV. Enhancement by cholinergic and a — adrenergic stimulation. J. Expt. Med. 136, 556–567.Google Scholar
  135. 135.
    ANDERSSON, R., NILSSON, K., WIKBERG, J., JOHANSON, S., MOHME-LUNHOLM, E. and LUNDHOLM, L., (1975). Cyclic nucleotides and the contraction of smooth muscle. In: Advances in cyclic nucleotides research. Vol. 5. Eds. G.I. Drummond, P. Greengard and G.A. Robison. Raven Press N.Y. p.p. 491–518.Google Scholar
  136. 136.
    ANDERSSON, R., (1972). Cyclic AMP and calcium ions in mechanical and metabolic responses of smooth muscle; influence of some hormones and drugs. Acta Physiol. Scand. suppl. 382, 1–59.PubMedGoogle Scholar
  137. 137.
    KADOWITZ, P.J., JOINER, P.D., HYMAN, A.L. and GEORGE, W.J., (1975). Influence of prostaglandins E1 and F on pulmonary vascular resistence, isolated lobar vessels and cyclic nucleotide levels. J. Pharmacol. Exp. Ther. 192, 677–687.PubMedGoogle Scholar
  138. 138.
    GRODZINSKA, L., PANCZENKO, B and GRYGLEWSKI, R.J., (1975). Generation of prostaglandin E-like material by the guinea pig trachea contracted by histamine. J. Pharm. Pharmacol. 27, 88–91.PubMedGoogle Scholar
  139. 139.
    PUGLISI, L., BERTI, F., BOSISIO, E., LONGIAVE, D. and NICOSIA, S., (1976). Ascorbic acid and PGF antagonism on tracheal smooth muscle. In: Advances in prostaglandin and thromboxane research. Vol. 1, Eds. B. Samuelsson and R. Paoletti. Raven Press N.Y. p.p. 503–506.Google Scholar
  140. 140.
    YEN, S.S., MATHE, A.A. and DUGAN, J.J., (1976). Release of prostaglandins from healthy and sensitized guinea pig lung and trachea by histamine. Prostaglandins 11, 227–239.PubMedGoogle Scholar
  141. 141.
    MAIN, I.H.M., (1964). The inhibitory action of prostaglandins on respiratory smooth muscle. Br. J. Pharmacol. 22, 511–519.Google Scholar
  142. 142.
    HORTON, E.W. and MAIN, I.H.M., (1965). A comparison of the actions of prostaglandins F and E1 on smooth muscle. Br. J. Pharmacol. 24, 470.Google Scholar
  143. 143.
    SWEATMAN, W.J.F. and COLLIER, H.O.J., (1968). Effects of prostaglandins on human bronchial muscle. Nature 217, 69.PubMedGoogle Scholar
  144. 144.
    CUTHBERT, M.F., (1973). Prostaglandins and respiratory smooth muscle. In: The prostaglandins, pharmacological and therapeutic advances. Ed. M.F. Cuthbert. W. Heinemann Ltd., London, p.p. 253–285.Google Scholar
  145. 145.
    SMITH, A.P., (1976). Prostaglandins and the respiratory system. In: Advances in prostaglandins research. Prostaglandins: physiological, pharmacological and pathological aspects. Ed. S.M.M. Karim, M.T.P. Press. Ltd., pp. 83–102.Google Scholar
  146. 146.
    ROSENTHALE, M. E., DERVINIS, A. and STRIKE, D., (1976). Actions of prostaglandins on the respiratory tract of animals. In: Advances in prostaglandin and thromboxane research. Vol. 1. Eds. B. Samuelsson and R. Paoletti. Raven Press N.Y. p.p. 477–493.Google Scholar
  147. 147.
    OREHEK, J., DOUGLAS, J.S., LEWIS, A.J., BOUHUYS, A., (1973). Prostaglandin regulation of airway smooth muscle tone. Nature New Biol. 245, 84–85.PubMedGoogle Scholar
  148. 148.
    FARMER, J.B., FARRAR, D.G. and WILSON, J., (1974). Antagonism of tone and prostaglandin mediated responses in a tracheal preparation by indomethacin and SC-19220. Br. J. Pharmacol. 52, 559–565.PubMedGoogle Scholar
  149. 149.
    LAMBLEY, J. and SMITH, A.P., (1975). The effect of arachi-donic acid, indomethacin and SC-19220 on guinea pig tracheal tone. Eur. J. Pharmacol. 30, 148.PubMedGoogle Scholar
  150. 150.
    GRÙEN, K., HEDQVIST, P. and SVANBORG, N., (1974). Increased plasma levels of 15-keto-13:14 dihydro-prostaglandin F after allergen-provoked asthma in man. The Lancet 14, 1419–1421:Google Scholar
  151. 151.
    NEMOTO, T., AOKI, H., IKE, A., YAMADA, K., KONDO, T., KOBAYASHI, S. and INAGAWA, T., (1976). Serum prostaglandin levels in asthmatic patients. J. Allergy Clin. Immunol. 57, 89–94.PubMedGoogle Scholar
  152. 152.
    MATHE, A.A., HEDQVIST, P., HOLMGREN, A. and SVANBORG, N., (1973). Bronchial hyperreactivity to prostaglandin F and histamine in patients with asthma, Br. Med. J. 1, 193–196.PubMedGoogle Scholar
  153. 153.
    HORTON, E.W., (1975). Prostaglandins. A short review. Scot. Med. J. 20, 155–160.PubMedGoogle Scholar
  154. 154.
    NICOSIA S. and GALLI, G., (1974). A rapid gaschromatographic-mass spectrometric method for prostaglandin analysis at pi-comole levels. Anal. Biochem. 61, 192.PubMedGoogle Scholar
  155. 155.
    BANERJER, S., DEB, C. and BELAVADY, B., (1952) Effect of scurvy on glutathione and dehydroascorbic acid in guinea pig tissues. J. Biol. Chem. 195, 271–276.Google Scholar
  156. 156.
    SAMUELSSON, B and HAMBERG, M, (1974). Role of endoperoxides in the biosynthesis and action of prostaglandins. In: Prostaglandin synthetase inhibitors. Eds. H.J. Robinson and J.R. Vane, Raven Press N.Y. p.p. 107–119.Google Scholar
  157. 157.
    NUGTEREN, D.H., BEERTHUIS, R.K. and VAN DORP, D.A., (1966). The enzymic conversion of all-cis 8, 11, 14-eicosatrienoic acid into prostaglandin E-. Rec. Trav. Chim. Pays Bas 85, 405–419.Google Scholar
  158. 158.
    MIYARES, C.M., REYESDIAZ, J.M., GUEVARA, F.S., COLLAZO, A.A. and AVILA, F., (1973). Altas dosis de vitamin Cenel asma bronquial. Rev. Cub. Med. 12, 327.Google Scholar
  159. 159.
    ZUSKIN, E., LEWIS, A.J. and BOUHUYS, A., (1973). Inhibition of histamine induced airway constriction by ascorbic acid. J. Allergy Clin. Immunol. 51, 218–226.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • L. Puglisi
    • 1
  • F. Maggi
  1. 1.Institute of Pharmacology and PharmacognosyUniversity of MilanoMilanoItaly

Personalised recommendations